| Authors: |
Liao W; Division of Cardiovascular Sciences, School of Medical Sciences, University of Leicester, Leicester, UK. Electronic address: weiqi.liao@leicester.ac.uk., Rashid M; Division of Cardiovascular Sciences, School of Medical Sciences, University of Leicester, Leicester, UK., Brookes CL; Leicester Clinical Trials Unit, University of Leicester, Leicester, UK., Barber S; Leicester Clinical Trials Unit, University of Leicester, Leicester, UK., Turner RM; Medical Research Council Clinical Trials Unit at UCL, UK., Gravel GM; Montreal Heart Institute, Université de Montréal, Montréal, Quebec, Canada., Petrie MC; School of Cardiovascular and Metabolic Health, University of Glasgow, Glasgow, UK., Lipsic E; Department of Cardiology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands., Doenst T; Jena University Hospital, Friedrich-Schiller-University of Jena, Jena, Germany., Fremes S; Department of Surgery, University of Toronto for Fremes,Toronto, Canada., Murphy GJ; Division of Cardiovascular Sciences, School of Medical Sciences, University of Leicester, Leicester, UK; Leicester Clinical Trials Unit, University of Leicester, Leicester, UK. |